Efficacy of Denifanstat for the Treatment of Metabolic Dysfunction–Associated Steatohepatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2b trial
Lancet Gastroenterol Hepatol 2024 Oct 10;[EPub Ahead of Print], R Loomba, P Bedossa, K Grimmer, G Kemble, E Bruno Martins, W McCulloch, M O'Farrell, WW Tsai, J Cobiella, E Lawitz, M Rudraraju, SA HarrisonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.